Biotech

All Articles

OS Therapies refiles $6M IPO to fund HER2 medication, preclinical ADCs

.Operating system Therapies will certainly list on the NYSE American sell swap today using a $6.4 mi...

ALX's waning CD47 response rate sends out supply spiraling down

.ALX Oncology's stage 2 stomach cancer action price has actually compromised. After viewing its CD47...

Ionis centers eye ailment coming from intendeds of Roche-partnered possibility after information dissatisfy

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has actually disappointed expecta...

Biogen's chief executive officer pointed out no risky handle 2023. He prepares to become bold

.While Biogen's pharma peers are hunting for late-stage resources along with little danger, chief ex...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has actually been a biotech seeking a pipe after it junked its own lead resources ...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually restored civil liberties to an early Alzheimer's ailment system to Denali Thera...

Takeda faucets new mind of US oncology organization-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable management hirings, firings and...

Vertex, hammered through AATD once again, loses 2 properties on dispose of stack

.Tip's try to address an uncommon genetic illness has attacked another obstacle. The biotech shook 2...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of team

.Vir Biotechnology's second-quarter incomes record wasn't short of huge news. The company accepted a...

Galapagos stops briefly CAR-T tissue treatment trial over Parkinsonism scenario

.Galapagos has stopped application in a trial of a BCMA-directed CAR-T tissue therapy, pumping the b...